Petrova Penka Insider Trades

Insider Trading History

Track insider trading activity for Petrova Penka. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Trillium Therapeutics
Trillium Therapeutics TRIL
Chief Development Officer
Holding Value $0 0 shares
Last Trade
Nov 17, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$5.84M 316,822 shares
$18.44
$19.86
Trillium Therapeutics
Trillium Therapeutics TRIL
Chief Development Officer
Holding Value $106k 5,312 shares
Last Trade
Apr 08, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$59.4k 5,312 shares
$11.18
$19.86
Trillium Therapeutics
Trillium Therapeutics TRIL
Chief Development Officer
Holding Value $1.67M 83,960 shares
Last Trade
Apr 08, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$59.4k 5,312 shares
$11.18
$19.86
Trillium Therapeutics
Trillium Therapeutics TRIL
Chief Development Officer
Holding Value $0 0 shares
Last Trade
Apr 08, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$58.9k 5,312 shares
$11.09
$19.86
Trillium Therapeutics
Trillium Therapeutics TRIL
Chief Development Officer
Holding Value $1.72M 86,668 shares
Last Trade
Mar 10, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$59.3k 5,312 shares
$11.16
$19.86
Trillium Therapeutics
Trillium Therapeutics TRIL
Chief Development Officer
Holding Value $106k 5,312 shares
Last Trade
Mar 10, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$59.3k 5,312 shares
$11.16
$19.86
Trillium Therapeutics
Trillium Therapeutics TRIL
Chief Development Officer
Holding Value $0 0 shares
Last Trade
Mar 10, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$58.9k 5,312 shares
$11.08
$19.86
Trillium Therapeutics
Trillium Therapeutics TRIL
Chief Development Officer
Holding Value $90.9k 4,574 shares
Last Trade
Feb 09, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$7.22k 508 shares
$14.22
$19.86
Trillium Therapeutics
Trillium Therapeutics TRIL
Chief Development Officer
Holding Value $0 0 shares
Last Trade
Feb 09, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$7.2k 508 shares
$14.17
$19.86
Trillium Therapeutics
Trillium Therapeutics TRIL
Chief Development Officer
Holding Value $10.1k 508 shares
Last Trade
Feb 09, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$7.22k 508 shares
$14.22
$19.86
Trillium Therapeutics
Trillium Therapeutics TRIL
Chief Development Officer
Holding Value $0 0 shares
Last Trade
Feb 08, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$67.2k 5,312 shares
$12.65
$19.86
Trillium Therapeutics
Trillium Therapeutics TRIL
Chief Development Officer
Holding Value $1.78M 89,376 shares
Last Trade
Feb 08, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$72.3k 5,312 shares
$13.61
$19.86
Trillium Therapeutics
Trillium Therapeutics TRIL
Chief Development Officer
Holding Value $106k 5,312 shares
Last Trade
Feb 08, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$72.3k 5,312 shares
$13.61
$19.86
Trillium Therapeutics
Trillium Therapeutics TRIL
Chief Development Officer
Holding Value $101k 5,082 shares
Last Trade
Jan 11, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$7.27k 508 shares
$14.32
$19.86
Trillium Therapeutics
Trillium Therapeutics TRIL
Chief Development Officer
Holding Value $10.1k 508 shares
Last Trade
Jan 11, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$7.27k 508 shares
$14.32
$19.86
Trillium Therapeutics
Trillium Therapeutics TRIL
Chief Development Officer
Holding Value $0 0 shares
Last Trade
Jan 11, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$7.73k 508 shares
$15.21
$19.86
Trillium Therapeutics
Trillium Therapeutics TRIL
Chief Development Officer
Holding Value $1.14M 57,292 shares
Last Trade
Jan 08, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$40.4k 2,604 shares
$15.51
$19.86
Trillium Therapeutics
Trillium Therapeutics TRIL
Chief Development Officer
Holding Value $51.7k 2,604 shares
Last Trade
Jan 08, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$40.4k 2,604 shares
$15.51
$19.86
Trillium Therapeutics
Trillium Therapeutics TRIL
Chief Development Officer
Holding Value $0 0 shares
Last Trade
Jan 08, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$40.4k 2,604 shares
$15.50
$19.86
Trillium Therapeutics
Trillium Therapeutics TRIL
Chief Development Officer
Holding Value $1.83M 92,084 shares
Last Trade
Jan 07, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$41.7k 2,708 shares
$15.39
$19.86

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up